Skip to main content

Table 2 The eradication rates of susceptibility-guided PPI-based therapy

From: Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication

 

Clarithromycin susceptible

n = 162

Clarithromycin resistant

n = 50

Total

n = 212

Success rate (%) (95% confidence interval)

Intention to treat

152/162

46/50

198/212

93.4 (90.1–96.7)

Per protocol

152/159

46/48

198/207

95.7 (92.9–98.4)